Share on StockTwits

Express Scripts Holding Company (NASDAQ:ESRX) VP David A. Norton sold 1,276 shares of the stock in a transaction that occurred on Monday, August 4th. The stock was sold at an average price of $71.02, for a total transaction of $90,621.52. Following the completion of the transaction, the vice president now directly owns 11,071 shares of the company’s stock, valued at approximately $786,262. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) traded up 0.10% on Wednesday, hitting $70.50. 4,938,256 shares of the company’s stock traded hands. Express Scripts Holding Company has a 1-year low of $59.20 and a 1-year high of $79.37. The stock has a 50-day moving average of $68.25 and a 200-day moving average of $71.79. The company has a market cap of $52.554 billion and a P/E ratio of 31.47.

Express Scripts Holding Company (NASDAQ:ESRX) last announced its earnings results on Tuesday, July 29th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $25.11 billion for the quarter, compared to the consensus estimate of $24.42 billion. During the same quarter in the previous year, the company posted $1.12 earnings per share. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. On average, analysts predict that Express Scripts Holding Company will post $4.87 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Cowen and Company cut their price target on shares of Express Scripts Holding Company from $77.00 to $76.00 in a research note on Thursday, July 31st. They now have a “market perform” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Express Scripts Holding Company in a research note on Wednesday, July 30th. They now have a $71.00 price target on the stock. Finally, analysts at Jefferies Group cut their price target on shares of Express Scripts Holding Company from $86.00 to $80.00 in a research note on Wednesday, July 30th. They now have a “buy” rating on the stock. Four equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Express Scripts Holding Company has a consensus rating of “Buy” and an average target price of $79.78.

Express Scripts, Inc is a pharmacy benefit management (NASDAQ:ESRX) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.